Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IDXG

Interpace Biosciences (IDXG) Stock Price, News & Analysis

Interpace Biosciences logo

About Interpace Biosciences Stock (NASDAQ:IDXG)

Advanced Chart

Key Stats

Today's Range
$0.77
$0.77
50-Day Range
$4.75
$10.40
52-Week Range
$2.57
$10.42
Volume
5,002 shs
Average Volume
6,816 shs
Market Capitalization
$3.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IDXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Interpace Biosciences and its competitors with MarketBeat's FREE daily newsletter.

IDXG Stock News Headlines

PDI: Inflection Point Ahead
PDI: Nothing Special... Yet
Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
PDI: Huge Income, But Please Know What You Own
PDI: A Decent Income Investment
PDI: An Opportunity To Lock In A 14% Yield On Cost
See More Headlines

IDXG Stock Analysis - Frequently Asked Questions

Interpace Biosciences, Inc. (NASDAQ:IDXG) announced its quarterly earnings data on Monday, November, 4th. The business services provider reported $0.31 EPS for the quarter. The business services provider had revenue of $12.30 million for the quarter. Interpace Biosciences had a net margin of 10.39% and a negative trailing twelve-month return on equity of 8.09%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Interpace Biosciences investors own include Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Dynavax Technologies (DVAX), Bristol Myers Squibb (BMY), Novavax (NVAX) and Histogenics (HSGX).

Company Calendar

Last Earnings
11/04/2024
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:IDXG
Employees
152
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$800 thousand
Pretax Margin
10.93%

Debt

Sales & Book Value

Annual Sales
$40.21 million
Cash Flow
$0.39 per share
Price / Cash Flow
1.99
Book Value
($14.16) per share
Price / Book
-0.05

Miscellaneous

Free Float
4,167,000
Market Cap
$3.40 million
Optionable
Not Optionable
Beta
0.76
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:IDXG) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners